Sivik Global Healthcare LLC Reduces Holdings in Encompass Health Corporation $EHC

Key Points

• Sivik Global Healthcare LLC reduced its holdings in Encompass Health Corporation by 51.6% during the second quarter, now owning 25,000 shares valued at approximately $3.07 million.
• Encompass Health recently announced an increased quarterly dividend of $0.19 per share, payable on October 15th, reflecting a rise from the previous dividend of $0.17.
• Analysts have recently boosted their price targets for Encompass Health, with UBS Group setting a target of $150, indicating a strong overall positive outlook for the company.

Sivik Global Healthcare LLC reduced its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 51.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,000 shares of the company's stock after selling 26,600 shares during the period. Encompass Health accounts for about 0.8% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 29th largest holding. Sivik Global Healthcare LLC's holdings in Encompass Health were worth $3,066,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of EHC. WPG Advisers LLC purchased a new position in Encompass Health during the 1st quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock valued at $42,000 after acquiring an additional 367 shares during the period. Arlington Trust Co LLC lifted its position in Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after acquiring an additional 125 shares during the period. Park Place Capital Corp purchased a new position in Encompass Health during the 2nd quarter valued at about $72,000. Finally, Caitong International Asset Management Co. Ltd lifted its position in Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock valued at $73,000 after acquiring an additional 115 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Performance

Shares of NYSE EHC opened at $122.02 on Friday. The firm has a 50 day moving average of $122.73 and a 200 day moving average of $116.50. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $12.29 billion, a price-to-earnings ratio of 23.88, a price-to-earnings-growth ratio of 2.14 and a beta of 0.93. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $127.86.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. The company had revenue of $136.30 million during the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, research analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.6%. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. Encompass Health's dividend payout ratio (DPR) is presently 14.87%.

Insider Transactions at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

EHC has been the subject of a number of recent research reports. KeyCorp lifted their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company an "overweight" rating in a research report on Tuesday, September 16th. Weiss Ratings reiterated a "buy (b+)" rating on shares of Encompass Health in a research note on Wednesday. Truist Financial lifted their price target on shares of Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research note on Thursday, August 14th. UBS Group lifted their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a "buy" rating in a research note on Thursday, October 2nd. Finally, Bank of America lifted their price target on shares of Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. One investment analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the stock. According to MarketBeat, Encompass Health presently has a consensus rating of "Buy" and a consensus target price of $139.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.